Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 319 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Respiratory Illness Clear all

Conditions: Infant Environmental Tobacco Smoke Exposure
Interventions: Motivational Interviewing intervention, Usual Care, Usual Care - Reduced Measurement; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 12 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Diseases
Interventions: Not listed
Lead sponsor: PC-HEART; Other
Eligibility: 18 Years and older
Enrollment: 349 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 14
States / cities: San Diego, California • Washington D.C., District of Columbia • Palm Beach, Florida + 11 more

Conditions: Advanced Care Planning, Shared Decision Making, Video Decision Aids, Communication Skills, Advance Directives, Natural Language Processing, Covid19
Interventions: VitalTalk communication skills training, ACP Decisions Video Program, Intervention training:, Medical Record Review; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 65 Years and older
Enrollment: 42,019 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Myopathy, Cognitive Impairment
Interventions: Biopsy/Ultrasound; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Intensive Care Unit Survivors, Informal Caregivers (Family and Friends)
Interventions: coping skills training, education program; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 417 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 4
States / cities: Chapel Hill, North Carolina • Durham, North Carolina • Pittsburgh, Pennsylvania + 1 more

Conditions: Acute Respiratory Failure
Interventions: Intubation with a sedative medication only, Intubation with a sedative medication and neuromuscular blockade agent; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Critically Ill, Respiratory Failure
Interventions: Inspiratory Muscle Trainer; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 90 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: High Altitude
Interventions: CHO+PRO, CHO; Dietary Supplement
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 18 Years to 39 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Influenza, Influenza-like Illness, Influenza Vaccines
Interventions: Egg based influenza vaccines, Recombinant influenza vaccines, Cell-culture based influenza vaccines; Biological
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15,448 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 9
States / cities: San Diego, California • Annapolis, Maryland • Bethesda, Maryland + 5 more

Conditions: Critical Illness, Respiratory Failure, Myopathy, Weakness
Interventions: Sham Treatment, Electrical stimulation; Device
Lead sponsor: Gerald Supinski; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Adjustment Disorder
Interventions: RE104 for Injection; Drug
Lead sponsor: Reunion Neuroscience Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 33
States / cities: Birmingham, Alabama • Tucson, Arizona • San Diego, California + 28 more

Conditions: Critical Illness, Heart Failure, Sepsis, Ards, Pneumonia, Trauma Injury
Interventions: Lift mobile mindfulness, Enlighten Recovery education program; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 3
States / cities: Los Angeles, California • Durham, North Carolina • Charleston, South Carolina

Conditions: Respiratory Illness
Interventions: Low Dose CT scan; Diagnostic Test
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Intensive Care Medicine, Acute Care Medical
Interventions: Not listed
Lead sponsor: Kirby Mayer; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Boca Raton, Florida • Durham, North Carolina

Conditions: Viral Respiratory Infection, Viral Respiratory Illnesses
Interventions: INNA-051, Placebo; Drug · Other
Lead sponsor: ENA Respiratory Pty Ltd; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: Baltimore, Maryland • Bethesda, Maryland • College Park, Maryland + 3 more

Conditions: Critical Illness, Acute Respiratory Failure
Interventions: Early mobilization intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 1,917 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 4
States / cities: Philadelphia, Pennsylvania • West Chester, Pennsylvania

Conditions: Brain Injuries, Dementia, Myopathies, Muscle Disorders
Interventions: Behavioral: Physical and functional rehabilitation, Behavioral: Cognitive, physical, & functional rehabilitation; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Influenza A
Interventions: VIR-2482 (450 mg), VIR-2482 (1200 mg), Placebo; Biological
Lead sponsor: Vir Biotechnology, Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 2,977 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 51
States / cities: Anniston, Alabama • Mobile, Alabama • Tempe, Arizona + 45 more

Conditions: Critical Illness, Wounds and Injury, Disease Attributes, Pathologic Processes
Interventions: Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg); Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 120 Years
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 8
States / cities: Birmingham, Alabama • Denver, Colorado • Cincinnati, Ohio + 5 more

Conditions: Acute Respiratory Failure
Interventions: IV amino acids, In-bed cycle ergometry exercise; Drug · Device
Lead sponsor: Clinical Evaluation Research Unit at Kingston General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 7
States / cities: Lexington, Kentucky • Baltimore, Maryland • The Bronx, New York + 4 more

Conditions: Infections, Heart Failure, COPD Exacerbation, Asthma, Gastrointestinal Diseases, Cardiac Event, Arrythmia, Renal Failure, Renal Disease, Rheumatic Diseases, Urologic Diseases, Neurologic Disorder, Hematologic Diseases, Oncology Problem, Shock, Critical Illness
Interventions: Health Information Exchange (HIE) platform; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,006 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ARDS, Sepsis, Pneumonia
Interventions: Blood collection, Urine Collection, Nasal, oral, and rectal swabs, Stool collection, Heat Moisture Exchange Filter collection, Tracheal Aspirate sample collection, Non-bronchoscopic bronchoalveolar lavage (NBBAL), Surveys, Short physical performance battery, Hand grip strength, CNS Vital Signs, Muscle Ultrasound, Muscle Strength, Spirometry, Lung Diffusion Testing (DLCO), Chest CT Scan; Other · Procedure · Radiation
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 20
States / cities: Fresno, California • Palo Alto, California • San Francisco, California + 12 more

Conditions: Acute Hypoxemic Respiratory Failure
Interventions: L-Citrulline, Placebo; Drug
Lead sponsor: Asklepion Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Pulmonary Disease, Critical Illness
Interventions: There is no intervention in this observational study; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Reducing Environmental Tobacco Smoke in Neonatal Intensive Care Unit (NICU) Infants' Homes

Pain Assessment, Incidence & Nature in Heart Failure

Advance Care Planning: Communicating With Outpatients for Vital Informed Decision

Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness

Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers

INtubation With Sedation Only to Preserve Independent Respiratory Effort Trial

A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU

High Altitude Muscle Recovery

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

Treatment of Muscle Weakness in Critically Ill Patients

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress

Comprehensive Lung Health

Functional Incremental Stepping in Place Test (F-IST) Validation

A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age

Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial

ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

Nutrition and Exercise in Critical Illness

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

The APS Phenotyping Study

Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19

Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections